Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
- PMID: 40204170
- DOI: 10.1016/j.nbd.2025.106906
Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
Conflict of interest statement
Declaration of competing interest CHDI Foundation is a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, all research was conceptualized, planned and directed by all authors and the University of Antwerp or at the contract research organizations Psychogenics, Evotec SE and Rancho Biosciences. No other potential conflicts of interest exist.
LinkOut - more resources
Full Text Sources
